Rolapitant Side Effects
Medically reviewed by Drugs.com. Last updated on Jul 25, 2023.
Applies to rolapitant: oral tablet.
Serious side effects of Rolapitant
Along with its needed effects, rolapitant may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking rolapitant:
- Black, tarry stools
- difficult, burning, or painful urination
- lower back or side pain
- pale skin
- sore throat
- trouble breathing
- ulcers, sores, or white spots in the mouth
- unusual bleeding or bruising
- unusual tiredness or weakness
- Bladder pain
- bloody or cloudy urine
- frequent urge to urinate
Other side effects of Rolapitant
Some side effects of rolapitant may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Decreased appetite
- Acid or sour stomach
- stomach discomfort, upset, or pain
For Healthcare Professionals
Applies to rolapitant: intravenous emulsion, oral tablet.
Uncommon (0.1% to 1%): Abdominal distention, diarrhea, nausea, oral fungal infection
Common (1% to 10%): Dizziness, headache
Uncommon (0.1% to 1%): Disturbance in attention, dysgeusia, somnolence
Common (1% to 10%): Anemia, neutropenia
Common (1% to 10%): Decreased appetite
Common (1% to 10%): Hiccups[Ref]
Uncommon (0.1% to 1%): Myalgia
Uncommon (0.1% to 1%): Asthenia
Uncommon (0.1% to 1%): Insomnia
Rare (less than 0.1%): Anxiety, bruxism[Ref]
Rare (less than 0.1%): Hypertension, increased heart rate[Ref]
Rare (less than 0.1%): Blurred vision[Ref]
More about rolapitant
- Check interactions
- Compare alternatives
- Reviews (1)
- Dosage information
- During pregnancy
- Drug class: NK1 receptor antagonists
- En español
- Rolapitant drug information
- Rolapitant (Intravenous) (Advanced Reading)
- Rolapitant (Oral) (Advanced Reading)
Related treatment guides
1. Cerner Multum, Inc. UK Summary of Product Characteristics.
2. Product Information. Varubi (rolapitant). Tesaro Inc. 2015.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.